BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6420108)

  • 1. The importance of urinary immunoglobulin light chain isoelectric point (pI) in nephrotoxicity in multiple myeloma.
    Coward RA; Delamore IW; Mallick NP; Robinson EL
    Clin Sci (Lond); 1984 Feb; 66(2):229-32. PubMed ID: 6420108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoelectric points of urinary light chains in myelomatosis: analysis in relation to nephrotoxicity.
    Johns EA; Turner R; Cooper EH; Maclennan IC
    J Clin Pathol; 1986 Aug; 39(8):833-7. PubMed ID: 2427548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal failure in myeloma: relationship with isoelectric point of immunoglobulin light chains.
    Melcion C; Mougenot B; Baudouin B; Ronco P; Moulonguet-Doleris L; Vanhille P; Beaufils M; Morel-Maroger L; Verroust P; Richet G
    Clin Nephrol; 1984 Sep; 22(3):138-43. PubMed ID: 6435919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary N-acetyl-beta-D-glucosaminidase as an indicator of tubular damage in multiple myeloma.
    Coward RA; DeLamore IW; Mallick NP; Robinson LE
    Clin Chim Acta; 1984 Apr; 138(3):293-8. PubMed ID: 6426824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloma kidney cast nephropathy in a rat model of multiple myeloma.
    Smolens P; Venkatachalam M; Stein JH
    Kidney Int; 1983 Aug; 24(2):192-204. PubMed ID: 6415338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodular glomerulosclerosis associated with multiple myeloma. Role of light chain isoelectric point.
    Palant CE; Bonitati J; Bartholomew WR; Brentjens JR; Walshe JJ; Bentzel CJ
    Am J Med; 1986 Jan; 80(1):98-102. PubMed ID: 3079952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrotoxicity of Bence Jones proteins in the rat: importance of protein isoelectric point.
    Clyne DH; Pesce AJ; Thompson RE
    Kidney Int; 1979 Sep; 16(3):345-52. PubMed ID: 529681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kidney in myeloma.
    Hamblin TJ
    Br Med J (Clin Res Ed); 1986 Jan; 292(6512):2-3. PubMed ID: 3080049
    [No Abstract]   [Full Text] [Related]  

  • 9. Light chain multiple myeloma: an evaluation of its biochemical investigations.
    Zahari Sham SY; C Thambiah S; Samsudin IN; Lim SM
    Malays J Pathol; 2017 Dec; 39(3):311-315. PubMed ID: 29279596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double light-chain disease: a case report.
    Dalal FR; Winsten S
    Clin Chem; 1979 Jan; 25(1):190-2. PubMed ID: 104808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal impairment in myeloma: negative association with isoelectric point of excreted Bence-Jones protein.
    Norden AG; Flynn FV; Fulcher LM; Richards JD
    J Clin Pathol; 1989 Jan; 42(1):59-62. PubMed ID: 2466054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotoxic potential of Bence Jones proteins.
    Solomon A; Weiss DT; Kattine AA
    N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin light chain nephropathies.
    Sturgill BC; Tucker FL; Bolton WK
    Pathol Annu; 1987; 22 Pt 2():133-50. PubMed ID: 3120137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kappa light-chain myeloma with pleural involvement.
    Kwan WC; Lam SC; Klimo P
    Chest; 1984 Sep; 86(3):494-6. PubMed ID: 6432458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of retinol in patients with multiple myeloma: a preliminary study.
    Gavrilov V; Yermiahu T; Gorodischer R
    Am J Hematol; 2003 Nov; 74(3):202-4. PubMed ID: 14587052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal histological lesions and clinical syndromes in multiple myeloma. Renal Immunopathology Group.
    Pasquali S; Zucchelli P; Casanova S; Cagnoli L; Confalonieri R; Pozzi C; Banfi G; Lupo A; Bertani T
    Clin Nephrol; 1987 May; 27(5):222-8. PubMed ID: 3109793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal proteins and renal disease.
    Kyle RA
    Annu Rev Med; 1994; 45():71-7. PubMed ID: 8198402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proximal renal tubular function in myelomatosis: observations in the fourth Medical Research Council trial.
    Cooper EH; Forbes MA; Crockson RA; MacLennan IC
    J Clin Pathol; 1984 Aug; 37(8):852-8. PubMed ID: 6206095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How lab staff and the estimation of free light chains can combine to aid the diagnosis of light chain disease.
    Sinclair D; Wainwright L
    Clin Lab; 2007; 53(5-6):267-71. PubMed ID: 17605400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary alpha 1- and beta 2-microglobulin in light chain proteinuria.
    Honkanen E; Pettersson T; Teppo AM
    Clin Nephrol; 1995 Jul; 44(1):22-7. PubMed ID: 7554529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.